Ad
Will health technology and pharmaceutical policy services fall under the Commission’s health directorate or the more lobby-friendly internal market directorate? (Photo: Gusset/Flickr)

Health experts wary of commission reshuffle

Medical experts fear an organisational reshuffle in the European Commission will prioritise the economics of health care over patients' well-being, with significant implications for combating chronic diseases.

Incoming EU commission president Jean-Claude Juncker moved the health technology and pharmaceutical policy services from the Commission’s health directorate to the more lobby-friendly internal market directorate.

The services of the European Medicines Agency is responsible f...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here
Will health technology and pharmaceutical policy services fall under the Commission’s health directorate or the more lobby-friendly internal market directorate? (Photo: Gusset/Flickr)

Tags

Ad

Related articles

Ad
Ad